Back to Search Start Over

Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016)

Authors :
Francis Mégraud
Thomas Casswall
Alexandra Papadopoulou
Nicola L. Jones
Patrick Bontems
Benjamin D. Gold
Sibylle Koletzko
Marion Rowland
Yoram Elitsur
Nicolas Kalach
Armando Madrazo
Matjaz Homan
Samy Cadranel
Karen J. Goodman
Steve Czinn
Michal Kori
Jeannette Guarner
Source :
Journal of Pediatric Gastroenterology & Nutrition. 64:991-1003
Publication Year :
2017
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2017.

Abstract

Background Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition recommendations for the diagnosis and management of H pylori infection in children and adolescents is required. Methods A systematic review of the literature (time period: 2009-2014) was performed. Representatives of both societies evaluated the quality of evidence using GRADE (Grading of Recommendation Assessment, Development, and Evaluation) to formulate recommendations, which were voted upon and finalized using a Delphi process and face-to-face meeting. Results The consensus group recommended that invasive diagnostic testing for H pylori be performed only when treatment will be offered if tests are positive. To reach the aim of a 90% eradication rate with initial therapy, antibiotics should be tailored according to susceptibility testing. Therapy should be administered for 14 days, emphasizing strict adherence. Clarithromycin-containing regimens should be restricted to children infected with susceptible strains. When antibiotic susceptibility profiles are not known, high-dose triple therapy with proton pump inhibitor, amoxicillin, and metronidazole for 14 days or bismuth-based quadruple therapy is recommended. Success of therapy should be monitored after 4 to 8 weeks by reliable noninvasive tests. Conclusions The primary goal of clinical investigation is to identify the cause of upper gastrointestinal symptoms rather than H pylori infection. Therefore, we recommend against a test and treat strategy. Decreasing eradication rates with previously recommended treatments call for changes to first-line therapies and broader availability of culture or molecular-based testing to tailor treatment to the individual child.

Details

ISSN :
15364801 and 02772116
Volume :
64
Database :
OpenAIRE
Journal :
Journal of Pediatric Gastroenterology & Nutrition
Accession number :
edsair.doi.dedup.....920e6f12f3f26227717fa95feba40df9
Full Text :
https://doi.org/10.1097/mpg.0000000000001594